Chemistry & Biology
Copper-Dependent Activation of Nrf2 by Diphenols
Determination of GSH
Dinkova-Kostova, A.T., Liby, K.T., Stephenson, K.K., Holtzclaw, W.D., Gao, X.,
Suh, N., Williams, C., Risingsong, R., Honda, T., Gribble, G.W., et al. (2005).
Extremely potent triterpenoid inducers of the phase 2 response: correlations
of protection against oxidant and inflammatory stress. Proc. Natl. Acad. Sci.
USA 102, 4584–4589.
Reduced glutathione was measured as described elsewhere (Kamencic et al.,
2000). Cells were seeded at 0.5 3 105 cells per well in 24-well plates. After
overnight incubation, cells were treated with 20 mM BSO or 2 mM SFN for
24 hr and then were lysed. Cell lysates (100 ml) were incubated with 100 ml
PBS containing 80 mM monochlorobimane (mCB) and 1 U/ml glutathione
S-transferase for 1 hr at 25ꢂC. Formation of the GS-mCB adduct was quanti-
fied by its fluorescence with excitation at 390 nm and emission at 490 nm.
Eggler, A.L., Liu, G., Pezzuto, J.M., van Breemen, R.B., and Mesecar, A.D.
(2005). Modifying specific cysteines of the electrophile-sensing human
Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2.
Proc. Natl. Acad. Sci. USA 102, 10070–10075.
Western Blot Analysis
Halliwell, B., and Gutteridge, J.M.C. (2007). Free radicals in biology and medi-
cine, 4th ed. (New York: Oxford University Press).
Whole-cell extracts were prepared as described elsewhere (Wang et al., 2006).
Briefly, cells were lysed in 0.1 M HEPES (pH 7.4), containing 0.5 M KCl, 5 mM
MgCl2, 0.5 mM EDTA, and 20% glycerol that was supplemented with
protease inhibitors (Roche Diagnostics). Proteins (30 mg) were separated
by SDS-PAGE. Immunoblotting was performed as described elsewhere
(O’Connor et al., 1999).
Hayes, J.D., and McMahon, M. (2009). NRF2 and KEAP1 mutations: perma-
nent activation of an adaptive response in cancer. Trends Biochem. Sci. 34,
176–188.
Higgins, L.G., Kelleher, M.O., Eggleston, I.M., Itoh, K., Yamamoto, M., and
Hayes, J.D. (2009). Transcription factor Nrf2 mediates an adaptive response
to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects
of electrophiles, peroxides and redox-cycling agents. Toxicol. Appl. Pharma-
col. 237, 267–280.
Statistical Analysis
Statistical comparisons were performed by the unpaired Student’s t test.
Jia, Z., Zhu, H., Misra, B.R., Li, Y., and Misra, H.P. (2008). Dopamine as a potent
inducer of cellular glutathione and NAD(P)H:quinone oxidoreductase 1 in PC12
neuronal cells: a potential adaptive mechanism for dopaminergic neuroprotec-
tion. Neurochem. Res. 33, 2197–2205.
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures and can be found with this
Jin, Y., and Penning, T.M. (2007). Aldo-keto reductases and bioactivation/
detoxication. Annu. Rev. Pharmacol. Toxicol. 47, 263–292.
ACKNOWLEDGMENTS
Kamencic, H., Lyon, A., Paterson, P.G., and Juurlink, B.H. (2000). Monochloro-
bimane fluorometric method to measure tissue glutathione. Anal. Biochem.
286, 35–37.
We thank Nobunao Wakabayashi (Johns Hopkins University) for providing the
Keap1 expression plasmid, Stewart Finlayson for expression and purification
of recombinant Keap1, and Ian M. Eggleston and Sebastien Ronseaus for
assistance with mass spectrometry. We thank Rene´ V. Bensasson (Labora-
toire de Chimie des Substances Naturelles, MNHN, Paris), Mike McMahon,
and Colin J. Henderson for helpful discussions. This work was supported by
Cancer Research UK (C4639/A5661 and C20953/A10270), Research Councils
UK, the Royal Society, and the American Cancer Society (RSG-07-157-01-
CNE).
Kensler, T.W., Wakabayashi, N., and Biswal, S. (2007). Cell survival responses
to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Phar-
macol. Toxicol. 47, 89–116.
Kuo, H.W., Chen, S.F., Wu, C.C., Chen, D.R., and Lee, J.H. (2002). Serum and
tissue trace elements in patients with breast cancer in Taiwan. Biol. Trace
Elem. Res. 89, 1–11.
Lee, J.M., Anderson, P.C., Padgitt, J.K., Hanson, J.M., Waters, C.M., and
Johnson, J.A. (2003). Nrf2, not the estrogen receptor, mediates catechol
estrogen-induced activation of the antioxidant responsive element. Biochim.
Biophys. Acta 1629, 92–101.
Received: September 15, 2009
Revised: December 12, 2009
Accepted: December 15, 2009
Published: January 28, 2010
Li, Y., and Trush, M.A. (1993). Oxidation of hydroquinone by copper: chemical
mechanism and biological effects. Arch. Biochem. Biophys. 300, 346–355.
Li, Y., Trush, M.A., and Yager, J.D. (1994). DNA damage caused by reactive
oxygen species originating from
a copper-dependent oxidation of the
REFERENCES
2-hydroxy catechol of estradiol. Carcinogenesis 15, 1421–1427.
Li, Y., Seacat, A., Kuppusamy, P., Zweier, J.L., Yager, J.D., and Trush, M.A.
(2002). Copper redox-dependent activation of 2-tert-butyl(1,4)hydroquinone:
formation of reactive oxygen species and induction of oxidative DNA damage
in isolated DNA and cultured rat hepatocytes. Mutat. Res. 518, 123–133.
Apelgot, S., Coppey, J., Fromentin, A., Guille, E., Poupon, M.F., and Roussel,
A. (1986). Altered distribution of copper (64Cu) in tumor-bearing mice and rats.
Anticancer Res. 6, 159–164.
Asanuma, M., Miyazaki, I., Diaz-Corrales, F.J., and Ogawa, N. (2004). Quinone
formation as dopaminergic neuron-specific oxidative stress in the pathogen-
esis of sporadic Parkinson’s disease and neurotoxin-induced parkinsonism.
Acta Med. Okayama 58, 221–233.
Linder, M.C., and Hazegh-Azam, M. (1996). Copper biochemistry and molec-
ular biology. Am. J. Clin. Nutr. 63, 797S–811S.
Lou, H., Du, S., Ji, Q., and Stolz, A. (2006). Induction of AKR1C2 by phase II
inducers: identification of a distal consensus antioxidant response element
regulated by NRF2. Mol. Pharmacol. 69, 1662–1672.
Bensasson, R.V., Zoete, V., Dinkova-Kostova, A.T., and Talalay, P. (2008).
Two-step mechanism of induction of the gene expression of a prototypic
cancer-protective enzyme by diphenols. Chem. Res. Toxicol. 21, 805–812.
MacLeod, A.K., McMahon, M., Plummer, S.M., Higgins, L.G., Penning, T.M.,
Igarashi, K., and Hayes, J.D. (2009). Characterization of the cancer chemopre-
ventive NRF2-dependent gene battery in human keratinocytes: demonstration
that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls
cytoprotection against electrophiles as well as redox-cycling compounds.
Carcinogenesis 30, 1571–1580.
Cavalieri, E., Frenkel, K., Liehr, J.G., Rogan, E., and Roy, D. (2000). Estrogens
as endogenous genotoxic agents—DNA adducts and mutations. J. Natl.
Cancer Inst. Monogr. 27, 75–93.
Devling, T.W., Lindsay, C.D., McLellan, L.I., McMahon, M., and Hayes, J.D.
(2005). Utility of siRNA against Keap1 as a strategy to stimulate a cancer che-
mopreventive phenotype. Proc. Natl. Acad. Sci. USA 102, 7280–7285A.
Miyazaki, I., and Asanuma, M. (2009). Approaches to prevent dopamine
quinone-induced neurotoxicity. Neurochem. Res. 34, 698–706.
Dinkova-Kostova, A.T., Holtzclaw, W.D., Cole, R.N., Itoh, K., Wakabayashi, N.,
Katoh, Y., Yamamoto, M., and Talalay, P. (2002). Direct evidence that sulfhy-
dryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes
that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA 99,
11908–11913.
Motohashi, H., and Yamamoto, M. (2004). Nrf2-Keap1 defines a physiologi-
cally important stress response mechanism. Trends Mol. Med. 10, 549–557.
Nakamura, Y., Kumagai, T., Yoshida, C., Naito, Y., Miyamoto, M., Ohigashi, H.,
Osawa, T., and Uchida, K. (2003). Pivotal role of electrophilicity in glutathione
84 Chemistry & Biology 17, 75–85, January 29, 2010 ª2010 Elsevier Ltd All rights reserved